Wegovy approved to cut heart disease risks

The U.S. Food and Drug Administration approved an application to add cardiovascular benefits to Wegovy's label, making it the first weight-loss drug to also be cleared to reduce the risk of heart attack and stroke. Emory's Dr. Neil Winawer discusses what the new indication might mean.